1
Clinical Trials associated with Zhenjiang Cataplasm [Translation] Phase I clinical human tolerance trial of Zhenjiang Babu ointment
以中国健康成年受试者为研究对象,进行镇江巴布膏外用给药的人体耐受性试验,从安全的初始剂量开始,观察人体对镇江巴布膏的耐受性及其产生的不良反应,确定安全耐受的人用剂量,了解在此剂量下的不良反应,为制定镇江巴布膏Ⅱ期临床试验给药方案,提供安全的剂量范围及设计依据。
[Translation] Using healthy Chinese adult subjects as research subjects, a human tolerance trial of topical administration of Zhenjiang Babu Paste was conducted. Starting from a safe initial dose, the tolerance of the human body to Zhenjiang Babu Paste and the adverse reactions it produced were observed, and a safe and tolerable human dose was determined. The adverse reactions at this dose were understood, and a safe dosage range and design basis were provided for the formulation of the dosing regimen for the Phase II clinical trial of Zhenjiang Babu Paste.
100 Clinical Results associated with Zhenjiang Cataplasm
100 Translational Medicine associated with Zhenjiang Cataplasm
100 Patents (Medical) associated with Zhenjiang Cataplasm
100 Deals associated with Zhenjiang Cataplasm